AfDB presents its action plan for 2021-2030 period
28/06/2022 20:34, TUNIS/Tunisia

(TAP) - Officials of the African Development Bank (AfDB) presented at a workshop held in Gammarth Tuesday the action plan and vision of the bank in the development of pharmaceutical industry and vaccine for the period 2021-2030. They highlighted opportunities for cooperation between the Bank and the public and private sectors to develop the pharmaceutical industry locally and at the level of the African continent.

Director General of the Regional Office of the AfDB in Tunisia, Mohamed El Azizi told TAP the holding of this workshop, the first of its kind in Tunisia, aims to present the strategy of the AfDB in the field of promotion of the pharmaceutical industry and vaccine at local and African levels.

He said the AfDB has mobilized significant funds to promote the production of drugs, either locally or in African countries, in addition to funds and assistance to support the export of drugs and vaccines to countries in Africa.

The AfDB seeks to strengthen the capacity of drug production on the African continent and to ensure its pharmaceutical security due to the fragility of its health and pharmaceutical system, especially with the spread of the COVID-19 pandemic, he pointed out.

According to statistics presented by the AfDB Tuesday, African continent suffers from a dependence in terms of supply of medicines with 70% of medicines imported and a production of vaccines that does not exceed 1% of the needs of African countries.

For his part, Minister of Health Ali Mrabet told TAP the strategy of the AfDB offers significant opportunities for the public and private sectors in Tunisia to develop the manufacture of drugs and vaccines and promote exports to African countries.

He stressed that the development of the pharmaceutical industry is one of the four major axes on which rests the national health strategy, noting that the AfDB intends to support Tunisia in financing the production of drugs and vaccines and in increasing the country’s exports to Africa.

Minister of Economy and Planning Samir Saied noted that the AfDB has mobilised $ 111 billion in investments related to the pharmaceutical industry and vaccine.

He stressed that the role of the AfDB will be instrumental in achieving pharmaceutical security on the African continent, through partnership and cooperation between the Bank and its partners in the public and private sectors.

Tunisia has 35 companies operating in the pharmaceutical industry, whose production covers 75% of the local market. The export capacity of the sector amounts to 21% of domestic production.

Medicines manufactured in Tunisia are exported to 24 African countries in addition to the Gulf countries and Europe. Export revenues in 2021 amounted to about 280 million dinars, according to data provided to TAP by President of the National Chamber of Pharmaceutical Industries Tarek Hammami.

Twitter Updates Newsletter Signup Contact Us

To receive our newsletter,register

tel: 71889000
fax: 71883500, 71888999